Chemistree: The Vertically Integrated Venture The Cannabis Industry So Desperately Needs

Why Chemistree

Chemistree was established in 2018 as a solution to the crowded and cumbersome Canadian cannabis market. After recognizing the huge market potential of the US cannabis industry (experts estimate that the US cannabis market could be worth as much as $50 billion within the next decade), Chemistree chose to focus solely on the Pacific Northwestern markets of California and Washington state with plans to expand into the East Coast markets.

Chemistree’s corporate strategy is to acquire and develop vertically integrated cannabis assets; with strategic acquisitions, they will own and operate licensed cultivation, processing, distribution, and retail facilities. They plan to do this by leveraging their team’s decades of expertise in the cannabis industry and corporate finance. 

An Experienced Team

California and Canada were the first two regions to legalize medical cannabis (in 1996, and 2001 respectively). This means that cannabis professionals from these two areas have been able to gain a considerable head start in gaining industry experience, compared to others just entering the industry.

Since the legal cannabis industry is still in its infancy, experienced cannabis cultivators are much more difficult to find than other industry professionals. In a top quality growing operation, a management team of cannabis cultivation veterans with hands-on experience is optimal. While many companies employ personnel of all experience levels, cannabis is a highly competitive industry that moves much too quickly for those learning on the go. Leaders with a diverse skill set and lots of experience have the opportunity to capitalize on their operational experience.

Companies that are able to attract talented cannabis growers are at a clear advantage in navigating the complex cannabis industry. When Chemistree assembled their leadership team, they established that hands-on cannabis experience was essential. In order to reflect this necessity, the role of Chief Cannabis Officer was created. This demanding role requires a wealth of knowledge and experience in all aspects of cannabis business and industry. Chemistree founder Sheldon Aberman was selected for this role due to his extensive experience. Sheldon has been involved in the legal cannabis industry since 2003; he works the cultivation side of the business, and is sought after world-wide as one of the industry’s foremost experts on commercial cultivation. Sheldon has been involved in the design and management of thousands of commercial cannabis grows, and has built several multi-million dollar brands which include Black Label and Frost Box.

One team member with almost two decades of experience wasn’t enough for Chemistree — their chairman Justin Chorbajian has over 20 years of experience in cannabis retail as co-owner of Canada’s largest chain of privately owned hydroponic shops. Justin has made several appearances on this hit podcast Growing Exposed where he speaks about cannabis cultivation.

Chemistree didn’t stop there — they decided to add an advisor to their team. With over 25 years of experience in the cannabis industry, Dennis Hunter is an amazing asset to the Chemistree team. He is highly valuable due to his 3D rendering and computer-assisted design skills. During his lengthy and remarkable career, Dennis has helped to build brands like Care by Design, and Craft Canna. He was also selected as one of the 100 Most Influential Figures in the Cannabis Space in 2019 by High Times Magazine.

Cannabis experience alone was not enough to create the well-rounded team Chemistree desired; Chemistree President Karl Kottemeier has over 25 years of experience in the financial industry. During these 25+ years, Karl has raised over $150 million in equity capital.

Partnerships

Since 2018, Chemistree has been busy gathering assets and acquisitions to ensure self-sustainability as a vertically integrated company. This included strategic purchases in Washington State and California — two of the biggest states in the US cannabis market — and New Jersey, a currently untapped market that is positioned to explode upon full medical and recreational legalization.

Sugarleaf Farms, Washington State

In December 2018, Chemistree entered into an agreement with Sugarleaf Farms to acquire global brand marketing rights to the Sugarleaf brand outside of Washington State. Acting as “landlord” for Sugarleaf farms, Chemistree has rescued this struggling small company from the brink of failure and helped them to become profitable (a 239% increase in sales since Chemistree’s investment as a turnkey services provider). 

SugarLeaf strains are recognized as some of the most potent in the country. In fact, the strains White 99 and Presidential Kush are High Times Cannabis Cup award winners for “Best US Hybrid”, “Best Medical Hybrid”, and “People’s Choice Cup” categories. Sugarleaf products are already available in over 50 retail stores across Washington State with plans for further expansion to 200+ stores — Chemistree’s established distribution network will make it difficult for new cannabis companies to win shelf space in dispensaries.

Desert Hot Springs California

With experts suggesting that the California cannabis market alone is poised to generate more income than the entire Canadian cannabis market, Chemistree’s team of experts agreed that this state must be a target location for their operations.

In July 2018, after the completion of $4.5 million in financing, Chemistree purchased 9.55 acres of land in Desert Hot Springs, California. As this area is specifically designated as a Cannabis Cultivation Zone, Chemistree plans to operate a multi-phased cannabis cultivation facility in this location. 

Phase One of this operation will focus on a 66,000 ft.2 greenhouse cultivation facility, and a 5,000 ft.2 processing facility with targeted annual revenues of USD $14.5 million. Phase Two will focus on filling the Desert Hot Springs facility to capacity. This includes 128,000 ft.2 of cultivation area, 40,000 ft.2 of processing space, and a projected USD $23 million in annual revenues.

The Desert Hot Springs Facility will cultivate, process, and distribute the award-winning Sugarleaf brand to the burgeoning California marketplace, and will also introduce the manufacturing of edibles, oils, concentrates, and tinctures.

Applied Cannabis Sciences, New Jersey

In June 2019, Chemistree completed their investment in Applied Cannabis Sciences Partnership, and filed three applications for medical cannabis licensing in New Jersey. As an early license applicant, they plan to become a first mover in the New Jersey market. This partnership also solidifies their positioning on the East Coast, ensuring coast to coast coverage of the United States markets.

Conclusion

As marketing of cannabis companies, their products, and information about the industry itself is still in its infancy, the experts at Chemistree believe that the cannabis industry offers tremendous opportunity for growth. While there may be several competitors in this space, there are few that are able to offer the decades of experience held by their capable and qualified management team, or the vertically integrated structure of their acquired assets. 

Drip Email Marketing Campaign

Drip 1 - Subject: Exciting Opportunity with Chemistree

Looking for an exciting new investment opportunity in the growing Cannabis Industry? You’ve found it. Cannabis stock prices are at a current low, and there has never been a better time to enter the market.

The frontliners of the cannabis industry share some key characteristics:

• A strong management team with years of experience

• Access to the largest US Cannabis Markets (especially California, the Pacific Northwest, and the Eastern Seaboard)

• Vertical Integration from seed to sale

• Unique and compelling product offerings

• Adequate capitalization

We are proud to announce that we at Chemistree are following all these benchmarks of success. While the Canadian market has grown crowded and cumbersome, we have chosen to focus solely on California and the Pacific Northwest where there is tremendous opportunity for growth.

Visit us at https://chemistree.ca/investors/ to learn more about how we combine capital, experience, and strategy to make it all happen.

Drip 2 - Subject: Our Management Team

At Chemistree, we believe an experienced management team is key to growth, prosperity, and profitability in the Cannabis Industry. We would like to introduce our capable management team to you:

Karl Kottmeier, President and CEO

With 20 years of experience, Karl brings the necessary finance and administration skills to ensure that operations are equipped and financed to reach their full potential.

Sheldon Aberman, Director and Chief Cannabis Officer

With a reputation as one of the foremost experts on cannabis cultivation, Sheldon has the broad industry expertise in facility build-out, grow-room design and application of cutting-edge technologies to optimize cultivation, ensure quality and improve yields.

Nicholas Zitelli, Director

Also known as Nico Escondido, Nico brings worldwide recognition as the Chief Cannabis Officer for Trans High Corporation (THC),  the parent company of High Times magazine. He also has a deep understanding of genetics, garden technologies, lab testing, regulatory and compliance issues.

To learn more about our head honchos and the wealth of experience they bring to our operation, visit our About page here.

Drip 3 - Subject: Our Partnerships

Did you know that Chemistree is involved in partnerships with budding cannabis companies south of the border? We would like to introduce you to our exciting and successful partners:

Sugarleaf Farms, Washington State

Acting as “landlord” for Sugarleaf farms, Chemistree has rescued this struggling small company from the brink of failure and helped them to become profitable (a 239% increase in sales since Chemistree’s investment as a turnkey services provider). SugarLeaf brands are High Times Cannabis Cup award winners.

Applied Cannabis, New Jersey

Chemistree has applied for cultivation, processing, and dispensary licenses as part of a strategic partnership with Applied Cannabis. Although this project is in its infancy, there is huge potential for growth as the state moves closer and closer towards legalization.

For more information on our partnerships, view our pitch deck here.

Have investment questions about Chemistree? We’d love to hear from you! Call us at 604-689-7422, or email investor relations: info@chemistree.ca

Drip 4 - Subject: Chemistree Investment Information 

The time to invest in the West Coast Green Rush is now! Stock prices have never been cheaper, and the market is positioned to explode.

Chemistree is currently trading at $0.09 per share (down from $0.58 in April). That’s an enormous discount on a company that is currently growing in Washington State, poised to strike in California and New Jersey. 

With your investment today:

• A $.05 cent move to the upside produces a 56 percent return

• A $.09 cent move upwards yields a 100 percent return

• A return back to above the April 2019 high produces a whopping 400 percent return.

So what are you waiting for? Contact your broker about Chemistree today! 

(CSE: CHM) (OTCQB: CHMJF)

For more investment information, visit our Investors page here.

Drip 5 - Subject: Striking Cannabis Gold in California

We are excited to share with you that Chemistree is poised to strike Cannabis gold in California!

Chemistree has purchased and acquired permits to operate a multi-phased cannabis cultivation facility in Desert Hot Springs.

• Phase One  will focus on a 66,000 ft.2 greenhouse cultivation facility, and a 5,000 ft.2 processing facility with targeted annual revenues of USD $14.5 million.

• Phase Two will focus on filling the Desert Hot Springs facility to capacity. This includes 128,000 ft.2 of cultivation area, 40,000 ft.2 of processing space, and a projected USD $23 million in annual revenues.

The Desert Hot Springs Facility will cultivate, process, and distribute the award-winning Sugarleaf brand to the burgeoning California marketplace.

Looking to invest in this exciting venture? Visit our investment page here for more information. You can also call us at 604-689-7422 or email: info@chemistree.ca.

Drip 6 - Subject: The Future of the Cannabis Industry

The future of the Cannabis Industry in the United States is looking bright. 62% of Americans support the legalization of marijuana, and 41 out of 50 states have now legalized medicinal, recreational, or CBD-related products.

Also, the SAFE Banking Act (H.R. 595) — a bill that seeks to allow banks and financial institutions to work with businesses in the cannabis space — has passed the House and is on its way to the Senate. With strong bipartisan support in the House, it is hoped that it will get enough votes in the Senate to reach President Trump’s desk by year end.

All of these factors combined lead to a projected market forecast of USD $30+ billion by 2023.

Now is the perfect time to invest, as cannabis stock prices are low, and positioned to explode. With Chemistree currently trading at $0.09 per share, you stand to double your investment with only a $0.09 move upwards.

Visit our investment page here for more information on how you can invest.

Drip 7 - Subject: What Sets Chemistree Apart

Hello [Name],

To foster confidence in your investment, we wanted to share with you today what sets Chemistree apart from other early stage public cannabis companies.

Focus

We are focused on acquiring and developing vertically integrated cannabis assets. We leverage our management team’s deep experience in the cannabis industry and corporate finance to come out ahead of our competitors.

Early Movement

We provide turn-key solutions for the US-regulated cannabis industry; we are a front-runner on new state licensing opportunities. 

Experience

Very few people have decades of cannabis experience, but those who do will see things that others don’t. That is the foundation of Chemistree—our team is our advantage. Chemistree also possesses premier operating capabilities in cannabis cultivation, processing, distribution, including retail facilities.

Visit our Investors page here to discover how we combine capital, experience, and strategy to make it all happen.

Questions? Comments? Get in touch by sending us a message at info@chemistree.ca, or call 604-689-7422.